blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1778635

EP1778635 - ISOINDOLINE COMPOUNDS AND THEIR USES [Right-click to bookmark this link]
Former [2007/18]ISOINDOLINE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
[2011/02]
StatusNo opposition filed within time limit
Status updated on  02.03.2012
Database last updated on 14.09.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
CELGENE CORPORATION
7 Powder Horn Drive
Warren, NJ 07059 / US
[2007/18]
Inventor(s)01 / MULLER, George, W.
P.O. Box 3688
Rancho Santa Fe, CA 92067 / US
02 / MAN, Hon-Wah
27 Grant Way
Princeton, NJ 08540 / US
 [2010/36]
Former [2007/18]01 / MULLER, George, W.
250 Windmill Court
Bridgewater, NJ 08807 / US
02 / MAN, Hon-Wah
27 Grant Way
Princeton, NJ 08540 / US
Representative(s)Jones Day
Rechtsanwälte, Attorneys-at-Law, Patentanwälte
Prinzregentenstrasse 11
80538 München / DE
[N/P]
Former [2007/18]Jones Day
Rechtsanwälte, Attorneys-at-Law, Patentanwälte Prinzregentenstrasse 11
80538 München / DE
Application number, filing date05804207.827.07.2005
[2007/18]
WO2005US26680
Priority number, dateUS2004090027028.07.2004         Original published format: US 900270
[2007/18]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006025991
Date:09.03.2006
Language:EN
[2006/10]
Type: A2 Application without search report 
No.:EP1778635
Date:02.05.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 09.03.2006 takes the place of the publication of the European patent application.
[2007/18]
Type: B1 Patent specification 
No.:EP1778635
Date:27.04.2011
Language:EN
[2011/17]
Search report(s)International search report - published on:EP24.08.2006
ClassificationIPC:C07D209/46
[2007/18]
CPC:
C07D209/48 (EP,KR,US); C07D209/46 (EP,KR,US); A61K31/4035 (KR);
A61P1/04 (EP); A61P11/00 (EP); A61P11/06 (EP);
A61P17/04 (EP); A61P17/06 (EP); A61P19/02 (EP);
A61P25/00 (EP); A61P25/04 (EP); A61P25/16 (EP);
A61P25/24 (EP); A61P27/02 (EP); A61P29/00 (EP);
A61P35/00 (EP); A61P37/02 (EP); A61P37/06 (EP);
A61P37/08 (EP); A61P43/00 (EP); A61P9/00 (EP);
C07D209/66 (EP,US); C07D405/12 (EP,KR,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/18]
Extension statesAL23.02.2007
BA23.02.2007
HR23.02.2007
MK23.02.2007
YU23.02.2007
TitleGerman:ISOINDOLIN-VERBINDUNGEN UND DEREN VERWENDUNGEN[2011/02]
English:ISOINDOLINE COMPOUNDS AND THEIR USES[2011/02]
French:COMPOSÉS ISOINDOLINIQUES ET LEURS UTILISATIONS[2011/02]
Former [2007/18]ISOINDOLINZUSAMMENSETZUNGEN UND VERFAHREN ZU IHRER HERSTELLUNG UND VERWENDUNG
Former [2007/18]ISOINDOLINE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
Former [2007/18]COMPOSES D'ISOINDOLINE ET METHODES DE PRODUCTION ET D'UTILISATION DESDITS COMPOSES
Entry into regional phase23.02.2007National basic fee paid 
23.02.2007Designation fee(s) paid 
23.02.2007Examination fee paid 
Examination procedure13.02.2006Request for preliminary examination filed
International Preliminary Examining Authority: EP
23.02.2007Examination requested  [2007/18]
16.04.2007Amendment by applicant (claims and/or description)
22.07.2008Despatch of a communication from the examining division (Time limit: M06)
30.01.2009Reply to a communication from the examining division
09.11.2009Despatch of a communication from the examining division (Time limit: M04)
15.03.2010Reply to a communication from the examining division
08.12.2010Date of oral proceedings
27.12.2010Minutes of oral proceedings despatched
07.01.2011Communication of intention to grant the patent
14.03.2011Fee for grant paid
14.03.2011Fee for publishing/printing paid
Opposition(s)30.01.2012No opposition filed within time limit [2012/14]
Fees paidRenewal fee
13.07.2007Renewal fee patent year 03
14.07.2008Renewal fee patent year 04
10.07.2009Renewal fee patent year 05
26.07.2010Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT27.04.2011
BE27.04.2011
CY27.04.2011
CZ27.04.2011
DK27.04.2011
EE27.04.2011
FI27.04.2011
HU27.04.2011
LT27.04.2011
LV27.04.2011
NL27.04.2011
PL27.04.2011
RO27.04.2011
SE27.04.2011
SI27.04.2011
SK27.04.2011
TR27.04.2011
BG27.07.2011
IE27.07.2011
LU27.07.2011
GR28.07.2011
CH31.07.2011
LI31.07.2011
MC31.07.2011
IS27.08.2011
PT29.08.2011
[2013/45]
Former [2013/44]AT27.04.2011
BE27.04.2011
CY27.04.2011
CZ27.04.2011
DK27.04.2011
EE27.04.2011
FI27.04.2011
LT27.04.2011
LV27.04.2011
NL27.04.2011
PL27.04.2011
RO27.04.2011
SE27.04.2011
SI27.04.2011
SK27.04.2011
TR27.04.2011
BG27.07.2011
IE27.07.2011
LU27.07.2011
GR28.07.2011
CH31.07.2011
LI31.07.2011
MC31.07.2011
IS27.08.2011
PT29.08.2011
Former [2013/29]AT27.04.2011
BE27.04.2011
CY27.04.2011
CZ27.04.2011
DK27.04.2011
EE27.04.2011
FI27.04.2011
LT27.04.2011
LV27.04.2011
NL27.04.2011
PL27.04.2011
RO27.04.2011
SE27.04.2011
SI27.04.2011
SK27.04.2011
BG27.07.2011
IE27.07.2011
LU27.07.2011
GR28.07.2011
CH31.07.2011
LI31.07.2011
MC31.07.2011
IS27.08.2011
PT29.08.2011
Former [2013/25]AT27.04.2011
BE27.04.2011
CY27.04.2011
CZ27.04.2011
DK27.04.2011
EE27.04.2011
FI27.04.2011
LT27.04.2011
LV27.04.2011
NL27.04.2011
PL27.04.2011
RO27.04.2011
SE27.04.2011
SI27.04.2011
SK27.04.2011
IE27.07.2011
LU27.07.2011
GR28.07.2011
CH31.07.2011
LI31.07.2011
MC31.07.2011
IS27.08.2011
PT29.08.2011
Former [2012/35]AT27.04.2011
BE27.04.2011
CY27.04.2011
CZ27.04.2011
DK27.04.2011
EE27.04.2011
FI27.04.2011
LT27.04.2011
LV27.04.2011
NL27.04.2011
PL27.04.2011
RO27.04.2011
SE27.04.2011
SI27.04.2011
SK27.04.2011
IE27.07.2011
GR28.07.2011
CH31.07.2011
LI31.07.2011
MC31.07.2011
IS27.08.2011
PT29.08.2011
Former [2012/20]AT27.04.2011
BE27.04.2011
CY27.04.2011
CZ27.04.2011
DK27.04.2011
EE27.04.2011
FI27.04.2011
LT27.04.2011
LV27.04.2011
NL27.04.2011
PL27.04.2011
RO27.04.2011
SE27.04.2011
SI27.04.2011
SK27.04.2011
GR28.07.2011
CH31.07.2011
LI31.07.2011
MC31.07.2011
IS27.08.2011
PT29.08.2011
Former [2012/11]AT27.04.2011
BE27.04.2011
CY27.04.2011
CZ27.04.2011
DK27.04.2011
EE27.04.2011
FI27.04.2011
LT27.04.2011
LV27.04.2011
NL27.04.2011
PL27.04.2011
RO27.04.2011
SE27.04.2011
SI27.04.2011
SK27.04.2011
GR28.07.2011
MC31.07.2011
IS27.08.2011
PT29.08.2011
Former [2012/10]AT27.04.2011
BE27.04.2011
CY27.04.2011
CZ27.04.2011
DK27.04.2011
EE27.04.2011
FI27.04.2011
LT27.04.2011
LV27.04.2011
NL27.04.2011
RO27.04.2011
SE27.04.2011
SI27.04.2011
SK27.04.2011
GR28.07.2011
IS27.08.2011
PT29.08.2011
Former [2012/09]AT27.04.2011
BE27.04.2011
CY27.04.2011
CZ27.04.2011
EE27.04.2011
FI27.04.2011
LT27.04.2011
LV27.04.2011
NL27.04.2011
SE27.04.2011
SI27.04.2011
GR28.07.2011
IS27.08.2011
PT29.08.2011
PL26.09.2011
Former [2012/01]AT27.04.2011
BE27.04.2011
CY27.04.2011
FI27.04.2011
LT27.04.2011
LV27.04.2011
NL27.04.2011
SE27.04.2011
SI27.04.2011
GR28.07.2011
IS27.08.2011
PT29.08.2011
PL26.09.2011
Former [2011/52]AT27.04.2011
CY27.04.2011
FI27.04.2011
LT27.04.2011
LV27.04.2011
SE27.04.2011
SI27.04.2011
GR28.07.2011
IS27.08.2011
PT29.08.2011
PL26.09.2011
Former [2011/50]CY27.04.2011
FI27.04.2011
LT27.04.2011
LV27.04.2011
SE27.04.2011
SI27.04.2011
GR28.07.2011
IS27.08.2011
PT29.08.2011
PL26.09.2011
Former [2011/49]CY27.04.2011
FI27.04.2011
LT27.04.2011
SE27.04.2011
GR28.07.2011
PT29.08.2011
Former [2011/48]LT27.04.2011
SE27.04.2011
PT29.08.2011
Former [2011/47]LT27.04.2011
PT29.08.2011
Cited inInternational search[X]WO0025777  (CELGENE CORP [US]) [X] 1-29 * Examples *;
 [X]WO0134606  (CELGENE CORP [US], et al) [X] 1-30 * Examples *;
 [X]WO0145702  (CELGENE CORP [US], et al) [X] 1-29 * Examples *;
 [Y]WO2004060313  (CELGENE CORP [US], et al) [Y] 1-29 * Examples *;
 [PY]WO2004080423  (CELGENE CORP [US], et al) [PY] 1-29 * Examples *;
 [PY]WO2004080422  (CELGENE CORP [US], et al) [PY] 1-29 * Examples *;
 [A]  - MULLER G W ET AL, "Thalidomide analogs and PDE4 inhibition", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (19981006), vol. 8, no. 19, ISSN 0960-894X, pages 2669 - 2674, XP004139598 [A] 1-29 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0960-894X(98)00475-2
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.